This inventor holds 2 USPTO granted patents and 2 published patent applications. Top assignees: University of Notre Dame Du Lac, Wayne State University. Active years: 2011-2012.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
2 out of 388 
2 out of 603 
Years Active: 2011-2012
Title: Masahiro Ikejiri: Innovator in Matrix Metalloproteinase Inhibition
Introduction
Masahiro Ikejiri is a notable inventor based in Osaka, Japan. He has made significant contributions to the field of biochemistry, particularly in the development of inhibitors for matrix metalloproteinases. With a total of 2 patents, his work has implications for treating various medical conditions.
Latest Patents
Ikejiri's latest patents focus on novel compounds designed to inhibit matrix metalloproteinases. The inventions provide detailed formulations, methods of making these compounds, and their applications in treating diseases associated with matrix metalloproteinases. These compounds are crucial for advancing therapeutic options in medical science.
Career Highlights
Throughout his career, Masahiro Ikejiri has worked with prestigious institutions such as the University of Notre Dame Du Lac and Wayne State University. His experience in these academic environments has allowed him to collaborate with leading researchers and contribute to significant advancements in his field.
Collaborations
Some of his notable coworkers include Mijoon Lee and Mayland Chang. Their collaborative efforts have further enriched the research landscape in which Ikejiri operates.
Conclusion
Masahiro Ikejiri's innovative work in matrix metalloproteinase inhibitors showcases his dedication to advancing medical science. His contributions are vital for developing new treatments and improving patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile